Santori & Peters Inc’s Pediatrix Medical MD Stock Holding History

Santori & Peters Inc’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-70	Closed	-$3K	–	338
2017 Q4	$3K	Buy	+70	New	+$3.3K	﹤0.01%	525

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Santori & Peters Inc's MD Position: Q1 2018 in Review

Santori & Peters Inc sold out of Pediatrix Medical (MD) in Q1 2018, closing a stake of 70 shares — an estimated $3K sold.

Santori & Peters Inc first reported a position in MD in Q4 2017 and held it in 1 quarter. The position peaked at $3K in Q4 2017. 342 funds tracked by Wall St. Rank hold MD as of Q1 2018.

Santori & Peters Inc reported no remaining Pediatrix Medical position as of Q1 2018 after selling out during the quarter.
Santori & Peters Inc sold 70 Pediatrix Medical shares in Q1 2018, an estimated $3K.
Santori & Peters Inc first reported a position in Pediatrix Medical in Q4 2017 and held it in 1 quarter.
Santori & Peters Inc's Pediatrix Medical position peaked at $3K in Q4 2017.
342 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2018.

Based on Santori & Peters Inc's 13F filing for Q1 2018, filed 16 Apr 2018.